-
Carbapenemase Gene Transfer in CREC Across Hospitals
2026-08-26
This study integrates carbapenemase-gene detection, plasmid localization, conjugation assays, mobile-element profiling, and strain typing to examine carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. Its findings indicate that plasmid-associated blaNDM-1 and efficient horizontal transfer are central features of the observed resistance network, while clonal typing suggests both shared lineages and broader interdepartmental dissemination.
-
How Viruses Hijack FPN1 to Evade Antiviral Defense
2026-08-26
The reference study identifies a viral immune-evasion mechanism in which infection increases DTX3L-dependent polyubiquitination and degradation of ferroportin 1 (FPN1), the principal cellular iron exporter. FPN1 loss raises intracellular ferrous iron, which interferes with TBK1 and STING signaling, weakening type I interferon production and autophagy while facilitating viral replication.
-
Leucomycin Assays: From MIC to Mechanism
2026-08-25
Leucomycin, also known as kitasamycin, is more than a broad-spectrum macrolide: its multicomponent chemistry and rRNA target shape how antibacterial assays should be designed and interpreted. This guide connects historical susceptibility evidence with practical workflows for translational inhibition studies and macrolide resistance characterization.
-
Puromycin dihydrochloride: Selection & QC
2026-08-25
Puromycin dihydrochloride provides a practical way to select cells expressing the pac resistance gene and to impose controlled translational stress in eukaryotic or prokaryotic workflows. It should be titrated by cell type rather than applied at a universal dose, and it is not appropriate for selection systems lacking functional puromycin N-acetyltransferase.
-
Amikacin Disulfate: Mechanism & Research Use
2026-08-24
Amikacin disulfate is a semisynthetic aminoglycoside antibiotic and a research compound for studying 16S rRNA-dependent bacterial protein synthesis suppression. Its defined product specifications support controlled mechanism-of-action, ribosomal interaction, resistance, and protein-binding workflows.
-
Cycloheximide Workflow for Protein Turnover Studies
2026-08-24
Cycloheximide provides a rapid, cell-permeable way to separate new protein synthesis from protein degradation in cultured eukaryotic cells. This guide connects translational blockade to apoptosis assay design, caspase activity measurement, and mechanistic testing of the TRIM28–NLRP3 stability pathway.
-
Protease Inhibitor Cocktail: Workflow Guide
2026-08-23
Learn how an EDTA-free Protease Inhibitor Cocktail protects labile proteins in Western blot, co-IP, kinase, and signaling workflows. Practical dilution, handling, assay-selection, and troubleshooting guidance helps preserve protein integrity without chelating divalent cations.
-
Tiamulin (Thiamutilin) Research Workflows
2026-08-22
Tiamulin (Thiamutilin) combines targeted bacterial protein synthesis inhibition with investigational anti-inflammatory activity, making it useful for infection, inflammation, and pharmacokinetic studies. This workflow-oriented guide covers assay setup, species-aware metabolite analysis, dosing interpretation, and troubleshooting for reliable veterinary research.
-
Tetramethylrhodamine Ethyl Ester Perchlorate
2026-08-22
Tetramethylrhodamine ethyl ester perchlorate (TMRE, SKU C8197) is a rhodamine-like fluorescent dye for live-cell measurement of mitochondrial membrane potential. Its cationic, membrane-permeable behavior supports mitochondria fluorescence imaging and comparative assessment of mitochondrial dysfunction.
-
Leucomycin Impurity Analysis by HPLC-CAD and UV
2026-08-21
A 2021 Journal of Pharmaceutical and Biomedical Analysis study developed HPLC with charged aerosol detection and converted the approach to UV detection for quantifying leucomycin-related impurities without individual impurity reference standards. The validated UV method offered a more accessible quality-control workflow for bulk drugs and tablets while preserving the analytical insight provided by CAD.
-
Isorhamnetin: Oocyte Stress Research Workflow
2026-08-20
Isorhamnetin provides a practical way to connect oxidative-stress, apoptosis, endoplasmic-reticulum, and PI3K/Akt readouts in oocyte maturation experiments. This workflow translates concentration-response evidence into stock-preparation, assay-design, and troubleshooting decisions while keeping pathway claims model-specific.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-08-20
The Hoechst 33342/PI Double Staining Kit combines nuclear chromatin imaging with membrane-integrity analysis to classify viable, apoptotic, and membrane-compromised cells. Hoechst 33342 propidium iodide staining supports rapid fluorescent apoptosis assay workflows, but PI positivity alone does not establish a specific death mechanism.
-
Autophagy–Liver Metastasis Signature in Colorectal Cancer
2026-08-19
Bai et al. developed a six-gene prognostic signature that integrates autophagy and liver-metastasis biology in colorectal cancer using bulk and single-cell transcriptomic analyses. The signature links high-risk disease with immune dysfunction, potential immunotherapy resistance, macrophage polarization, and CD8+ T-cell exhaustion, while experimental assays provided tissue-level confirmation for selected biomarkers.
-
Melatonin, RIPK3, and Atrazine Kidney Injury
2026-08-19
This study identifies RIPK3-dependent necroptosis as a central mechanism of atrazine-induced renal tubular injury and shows that melatonin suppresses this pathway. By combining animal and cellular models with RIPK3 knockdown, molecular docking, and molecular dynamics, the work connects chemical exposure to regulated necrosis and provides a mechanistic basis for melatonin-mediated nephroprotection.
-
Prochlorperazine-Induced Neuroleptic Malignant Syndrome
2026-08-18
This case report identifies prochlorperazine as a potential trigger of neuroleptic malignant syndrome (NMS) in an older adult receiving a standard dose, despite initially unremarkable laboratory findings. Its practical contribution is to show why medication history, neurological examination, and serial clinical assessment may be more informative than creatine phosphokinase elevation alone when evaluating this emergency.